VivoSeq
Other

Intracytoplasmic Sperm Injection

0

Pipeline Programs

1

Active Trials

2

Companies Involved

Intracytoplasmic Sperm Injection is an early-stage landscape with 0 programs across 2 companies. The most active players are Ferring, Merck & Co..

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

10/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

20

clinical trials

Completed14 · 70%
Unknown status3 · 15%
Active, not recruiting1 · 5%
Terminated1 · 5%
Withdrawn1 · 5%

Trial Activity

20 trials

Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment
Active, not recruiting··N/A·NCT04751084·675 enrolled
Metformin in Intracytoplasmic Sperm Injection Cycles
Completed··Phase 2·NCT03088631·320 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)